{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:00:59Z","timestamp":1760979659419,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.brainresbull.2004.06.003","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T16:54:52Z","timestamp":1089132892000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Luigi F.","family":"Agnati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Valeria","family":"Vergoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emili","family":"Mart\u0131\u0301nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Hockemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Lluis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjell","family":"Fuxe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2004.06.003_BIB1","first-page":"S46","article-title":"Levodopa. Is toxicity a myth?","volume":"57","author":"Agid","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7091-0643-3_1","article-title":"Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia","volume":"65","author":"Agnati","year":"2003","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(95)00026-M","article-title":"On the cellular localization and distribution of carbonic anhydrase II immunoreactivity in the rat brain","volume":"676","author":"Agnati","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/BF00978370","article-title":"The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls","volume":"18","author":"Andrew","year":"1993","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/01.WNL.0000073136.00548.D4","article-title":"Adenosine A(2A) receptor antagonist treatment of Parkinson\u2019s disease","volume":"61","author":"Bara-Jimenez","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/sj.bjp.0704613","article-title":"Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists","volume":"135","author":"Behan","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"Bezard","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-4886(03)00250-4","article-title":"A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson\u2019s disease","volume":"184","author":"Bibbiani","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB9","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","article-title":"A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists","volume":"23","author":"Blum","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB10","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB11","first-page":"S70","article-title":"Molecular basis of levodopa-induced dyskinesias","volume":"47","author":"Calon","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jnen\/61.2.186","article-title":"Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias","volume":"61","author":"Calon","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1471-4159.2000.741229.x","article-title":"l-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion","volume":"74","author":"Camp","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB14","doi-asserted-by":"crossref","first-page":"46741","DOI":"10.1074\/jbc.M306451200","article-title":"Adenosine A2A-dopamine D2 receptor-receptor heteromerization. Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer","volume":"278","author":"Canals","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/syn.10066","article-title":"Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent l-DOPA and A2A receptor blockade plus l-DOPA in dopamine-denervated rats","volume":"44","author":"Carta","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0003-4975(02)03793-1","article-title":"Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons","volume":"74","author":"Cassada","year":"2002","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB17","first-page":"2694","article-title":"l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB18","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0306-4522(92)90291-9","article-title":"Adenosine-dopamine interactions in the brain","volume":"51","author":"Ferr\u00e9","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1353-8020(00)00063-8","article-title":"Adenosine\/dopamine interaction: implications for the treatment of Parkinson\u2019s disease","volume":"7","author":"Ferr\u00e9","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1523\/JNEUROSCI.22-03-01054.2002","article-title":"Persistent behavioral sensitization to chronic l-DOPA requires A2A adenosine receptors","volume":"22","author":"Fredduzzi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB23","first-page":"345","article-title":"Adenosine receptors and Parkinson\u2019s disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum","volume":"86","author":"Fuxe","year":"2001","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1471-4159.1996.66020501.x","article-title":"l-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress","volume":"66","author":"Han","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/01.WNL.0000081227.84197.0B","article-title":"Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD","volume":"61","author":"Hauser","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to l-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0014-4886(03)00064-5","article-title":"Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson\u2019s disease","volume":"183","author":"Henry","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.0022-3042.2001.00694.x","article-title":"Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson\u2019s disease","volume":"80","author":"Ikeda","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB30","first-page":"297","article-title":"Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson\u2019s disease","volume":"46","author":"Jellinger","year":"1995","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/exnr.2000.7350","article-title":"Combined use of the adenosine A(2A) antagonist KW-6002 with l-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys","volume":"162","author":"Kanda","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB32","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.npp.1300167","article-title":"Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration","volume":"28","author":"Karcz-Kubicha","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jnr.10426","article-title":"Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade","volume":"70","author":"Kihara","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.npp.1300181","article-title":"The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells","volume":"28","author":"Kudlacek","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB35","first-page":"183","article-title":"Neuroprotection by dopamine agonists","volume":"43","author":"Lange","year":"1994","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB37","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1471-4159.2003.01632.x","article-title":"Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia","volume":"84","author":"Lundblad","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/exnr.2002.7976","article-title":"Behavioral and anatomical effects of long-term l-dihydroxyphenylalanine (l-DOPA) administration in rats with unilateral lesions of the nigrostriatal system","volume":"177","author":"Mura","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0306-4522(94)00606-6","article-title":"Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson\u2019s disease","volume":"66","author":"Nisbet","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB40","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(98)00333-1","article-title":"Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia","volume":"352","author":"O\u2019Neill","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0196-9781(97)00258-1","article-title":"Hypothalamic neuropeptide Y and galanin in overweight rats fed a cafeteria diet","volume":"19","author":"Pedrazzi","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB43","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0968-0896(02)00648-X","article-title":"Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists","volume":"11","author":"Petzer","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB44","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/jm970099t","article-title":"Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson\u2019s disease","volume":"40","author":"Pezzella","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K","article-title":"Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats","volume":"39","author":"Pinna","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB47","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","article-title":"Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum","volume":"22","author":"Popoli","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/exnr.2000.7624","article-title":"Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson\u2019s disease","volume":"169","author":"Rodriguez","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D","article-title":"Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system","volume":"401","author":"Rosin","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/jm9911480","article-title":"Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists","volume":"43","author":"Sauer","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.410440117","article-title":"Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress","volume":"44","author":"Sawada","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/34.5.3517144","article-title":"The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification","volume":"34","author":"Sternberger","year":"1986","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB53","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1046\/j.1460-9568.2000.00288.x","article-title":"Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum","volume":"12","author":"Stromberg","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB54","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0306-4522(02)00535-3","article-title":"Alterations in striatal neuropeptide mRNA produced by repeated administration of l-DOPA ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets","volume":"115","author":"Tel","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1124\/jpet.103.057083","article-title":"Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation","volume":"308","author":"Vortherms","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB57","first-page":"119","article-title":"Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain","volume":"2","author":"Wamsley","year":"1989","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.brainresbull.2004.06.003_BIB58","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0092-8674(02)00763-8","article-title":"Betagamma dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption","volume":"109","author":"Yao","year":"2002","journal-title":"Cell"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923004001455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923004001455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:53:04Z","timestamp":1759780384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923004001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0361923004001455"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2004.06.003","relation":{},"ISSN":["0361-9230"],"issn-type":[{"type":"print","value":"0361-9230"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2004.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}